Revance Therapeutic (RVNC) PT Lowered to $42 at Mizuho Securities

November 2, 2018 7:25 AM

Mizuho Securities analyst, Difei Yang, lowered the price target on Revance Therapeutic (NASDAQ: RVNC) to $42.00 (from $48.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found